By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AdkhabarAdkhabarAdkhabar
Notification Show More
Font ResizerAa
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Reading: FutureCeuticals Files Lawsuit Against NeuroRush Owner for Patent Infringement over Alleged Copycat Ingredient
Share
Font ResizerAa
AdkhabarAdkhabar
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Search
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Follow US
Adkhabar > Blog > News > FutureCeuticals Files Lawsuit Against NeuroRush Owner for Patent Infringement over Alleged Copycat Ingredient
FutureCeuticals Files Lawsuit Against NeuroRush Owner for Patent Infringement over Alleged Copycat Ingredient
News

FutureCeuticals Files Lawsuit Against NeuroRush Owner for Patent Infringement over Alleged Copycat Ingredient

Last updated: 15/09/2025 7:36 PM
Published: 15/09/2025
Share
SHARE

MOMENCE, Ill., Sept. 15, 2025 /PRNewswire/ — VDF FutureCeuticals, Inc. filed a lawsuit against Aura Scientific, asserting that its brain performance ingredient NeuroRush – an extract of whole coffee fruit – infringes multiple of FutureCeuticals’ patents covering technology relating to coffee fruit, including patents relating to the use of coffee fruit compositions to improve measures of cognitive performance. The lawsuit seeks monetary damages, a finding of willful infringement, and the complete cessation of sales of the infringing ingredient.

- Advertisement -

FutureCeuticals created the whole coffee fruit market segment and has owned patents covering extracts of whole coffee fruit for many years. Among its coffee fruit technology are patents related to coffee fruit compositions for brain performance discovered following multiple human clinical trials FutureCeuticals commissioned and then published.

- Advertisement -

“Aura Scientific’s ingredient NeuroRush offers nothing new, simply ‘piggybacking’ on FutureCeuticals’ renowned, robust science, and patented discoveries in the coffee fruit sector, with infringement as the clear consequence. Indeed, this is among the most open and willful infringements we’ve ever seen, harming not only us, but our many licensees currently selling products containing our genuine ingredients, CognatiQ® and NeuroFactor®,” J. Randal Wexler, FutureCeuticals’ Vice President & General Counsel shared.

- Advertisement -

Although FutureCeuticals’ lawsuit seeks to stop this infringement at its source with Aura Scientific, FutureCeuticals is committed to doing everything necessary to rid the market entirely of the infringing ingredient. Mr. Wexler continued, “At this point, we are left with no other option than to vigorously protect and defend our IP rights and the interests of our customers in court, to the fullest extent of the law.”

- Advertisement -

FutureCeuticals noted that several dietary supplement consumer brands, both large and small, have recently launched brands containing Aura Scientific’s NeuroRush in their formulations. Mr. Wexler concluded, “We encourage product manufacturers to carefully evaluate their decision to include the NeuroRush material in their products in light of FutureCeuticals’ clear IP rights. We take our obligations to protect our IP on behalf of ourselves and our customers very seriously.”

- Advertisement -

About VDF FutureCeuticals, Inc.
VDF FutureCeuticals, Inc. is a leader in the research, development, and manufacture of fruit, vegetable, and grain-based powders and extracts for the functional food, beverage, and dietary supplement markets. We unlock the synergistic power of plants through the discovery and research of innovative and nutritious plant-based ingredients. CognatiQ® and NeuroFactor® are available exclusively from FutureCeuticals. 

- Advertisement -

Logo – https://mma.prnewswire.com/media/2645826/FutureCeuticals_Logo.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/futureceuticals-files-lawsuit-against-neurorush-owner-for-patent-infringement-over-alleged-copycat-ingredient-302554476.html

- Advertisement -
Immuneering to Discuss Recently Announced Overall Survival Data from Phase 2a Clinical Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer Patients on Monday, September 29, 2025
Singapore Airshow 2026 Milestone Edition: 20 Years of Shaping the Aerospace Landscape as Asia-Pacific Drives Global Growth
15below Acquires Airport AI to Build the First Connected Communications Solution for Air Travel
Euro NCAP & DFRS join forces for safer roads in Europe
Protean eGov Technologies Begins AI-First Journey to Build Future-Ready Workforce
TAGGED:againstallegedcopycatfilesforfutureceuticals,infringementingredient,lawsuit,neurorushnewsoverownerpatent
Share This Article
Facebook Email Print
- Advertisement -

Follow US

Find US on Social Medias
FacebookLike
XFollow
YoutubeSubscribe

Weekly Newsletter

Subscribe to our newsletter to get our newest articles instantly!
Popular News
FibroBiologics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Health

FibroBiologics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

GlobeNews Wire
GlobeNews Wire
01/11/2025
Advanced Instruments is Now Merged Under the Nova Biomedical Name: One Unified Brand Driving Innovation
Meet Huion at CES 2026: Experience the Kamvas Gen 3 Tablets Hands-On
Daelim Belefic Expands U.S. Inventory of Ready-to-Ship UL-Listed Transformers for Data Centers and Crypto Mining
Questex’s IHIF Asia Attracts 100+ Global Investors Representing $107B AUM to Drive Hospitality Deal-Making
- Advertisement -
- Advertisement -
- Advertisement -

Categories

  • Automobile
  • Entertainment
  • E-Sports
  • Food
  • Health
  • Technology
  • LifeStyle
  • Travel

About Us

Through our news networks, we raise millions of users' awareness. We are among the world's most reputable news networks.
Quick Link
Top Categories
  • Entertainment

Subscribe US

Subscribe to our newsletter to get our newest articles instantly!

AdkhabarAdkhabar
Copyright © 2021 - 2025 AdKhabar. All Rights Reserved. POWERED BY Life Care News.
Join Us!
Subscribe to our newsletter and never miss our latest news, podcasts etc..
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?